financetom
Business
financetom
/
Business
/
Tesla's market value tumbles below $1 trillion as its Europe sales slump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's market value tumbles below $1 trillion as its Europe sales slump
Feb 25, 2025 10:52 AM

(Reuters) - Tesla's stock tumbled 8% on Tuesday, pushing its market value below $1 trillion for the first time since November after data showed the electric car maker's sales slumped in Europe in January.

The European Automobile Manufacturers Association reported that Tesla sales dropped 45% in Europe, compared with a 37% jump in overall sales of EVs in Europe.

The sales decline underscores Tesla's challenges following a dip in global deliveries last year that has raised pressure on CEO Elon Musk to roll out lower-priced models as well as the autonomous cars that he says underpin Tesla's future.

Tesla shares dropped to $305, leaving the company with a market capitalization of $981 billion, still over twice the combined value of General Motors, Ford Motor, Volkswagen, Toyota Motor, Hyundai Motor and BMW.

Some investors are also worried that Musk's role overseeing a radical downsizing of the federal government, at the behest of U.S. President Donald Trump, is potentially distracting his attention from Tesla as well as damaging the company's brand appeal to some consumers. Musk also heads privately held space rocket maker SpaceX and other private companies.

"He's a very hands-on operator, and if you're spending that much time in an office in the White House, how much time are you spending running all of your other companies, including the one that's publicly traded?" said Art Hogan, chief market strategist at B. Riley Wealth in Boston.

Concerns about potential over-investment in artificial intelligence are also weighing on Tesla, as well as Microsoft and Meta Platforms ahead of AI chip heavyweight Nvidia's quarterly report on Wednesday, Hogan said.

Tesla's stock recently traded at 112 times expected earnings, above its five-year average PE of 93, according to LSEG. By comparison, Ford's stock is valued at eight times earnings, and GM's is at seven.

Tesla bulls point to the company's plan to launch a new, cheaper electric vehicle and to Musk's promises to launch a paid autonomous car service.

With Tuesday's drop, Tesla shares remain up 51% over the past 12 months. Year-to-date, the stock is down 24%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aevex Files for IPO
Aevex Files for IPO
Mar 23, 2026
01:50 PM EDT, 03/23/2026 (MT Newswires) -- Aevex (AVEX), a defense technology contractor, said in a filing Monday that it plans to hold an initial public offering of its class A common shares. Some shareholders also plan to sell shares in the offering, according to a filing with the US Securities and Exchange Commission. Aevex said it expects to list...
CoStar must face rival's antitrust claims after US Supreme Court order
CoStar must face rival's antitrust claims after US Supreme Court order
Mar 23, 2026
WASHINGTON, March 23 (Reuters) - The U.S. Supreme Court on Monday declined to hear CoStar Group's ( CSGP ) bid to throw out antitrust claims lodged by real estate data provider Commercial Real Estate Exchange in a long-running legal fight between the rival companies. Here are some details: * The justices ruled without comment, keeping in place a lower appeals...
Go Residential REIT Raises US$75.1 Million in Financings
Go Residential REIT Raises US$75.1 Million in Financings
Mar 23, 2026
01:49 PM EDT, 03/23/2026 (MT Newswires) -- Go Residential REIT (GO-U.TO) on Monday said it raised a total of US$75.1 million in two offerings. The REIT raised US$37.5 million in its public offering of 3.8-million trust units at US$9.95 apiece, while its operating subsidiary concurrently closed a private placement of 3.8-million units at the offering price, for US$37.6 million. Go...
Gilead nears up to $2 billion buyout of biotech Ouro Medicines, FT reports
Gilead nears up to $2 billion buyout of biotech Ouro Medicines, FT reports
Mar 23, 2026
March 23 (Reuters) - Gilead Sciences ( GILD ) is close to reaching a deal to acquire Ouro Medicines, a biotech focused on immune disorder treatments, for up to $2 billion, the Financial Times reported on Monday. Under the proposed terms, Gilead will pay Ouro's investors roughly $1.5 billion upfront in cash and at least an additional $500 million if...
Copyright 2023-2026 - www.financetom.com All Rights Reserved